Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The study is performed to assess the efficacy of Vilaprisan (BAY1002670) in patients with
uterine fibroids compared to placebo and ulipristal. It is also aimed to evaluate the safety
of vilaprisan in subjects with uterine fibroids. Further, data on population pharmacokinetic
(PK)/ pharmacodynamic (PD) relationship for vilaprisan in subjects with uterine fibroids will
be supplemented.